share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 14 04:51
Summary by Futu AI
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares of the company on 03/13/2024, with an aggregate market value of $275,815.52. The shares were originally acquired on 04/20/2021 as pre-IPO shares from the issuer, with a cash payment made on the same date. This upcoming sale follows a series of transactions over the past three months, where a total of 150,000 shares were sold for gross proceeds of approximately $1.48 million.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 25,000 Class A shares of the company on 03/13/2024, with an aggregate market value of $275,815.52. The shares were originally acquired on 04/20/2021 as pre-IPO shares from the issuer, with a cash payment made on the same date. This upcoming sale follows a series of transactions over the past three months, where a total of 150,000 shares were sold for gross proceeds of approximately $1.48 million.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.